First identification of an Escherichia coli clinical isolate producing both metallo-β-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1

被引：40

作者：

Galani, I ^{[1
]}

Souli, M ^{[1
]}

Chryssouli, Z ^{[1
]}

Katsala, D ^{[1
]}

Giamarellou, H ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Dept Internal Med 4, Mol Biol Sect, GR-11527 Athens, Greece

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 08期

关键词：

bla(IBC-1); bla(VIM-2); carbapenemase; Escherichia coli; metallo-beta-lactamase; resistance;

D O I：

10.1111/j.1469-0691.2004.00913.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

An Escherichia coli strain with decreased susceptibility to carbapenems was isolated from a hospitalised patient in Athens, Greece. The strain was resistant to all beta-lactarns, including aztreonam, whereas the MIC of imipenem and meropenem was 0.5 mg/L. A positive EDTA-disk synergy test suggested the production of a metallo-beta-lactamase. PCR experiments revealed the presence of the bla(VIM-2), bla(IBC-1) and bla(TEM-1) genes. Resistance to beta-lactams was not transferable by conjugation. This is the first report of a clinical isolate of E. coli producing VIM-2, and the first report of the coexistence of bla(VIM-2) and bla(IBC-1) in a single clinical isolate.

引用

页码：757 / 760

页数：4

共 50 条

[21] Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal
Cardoso, O
Leitao, R
Figueiredo, A
Sousa, JC
Duarte, A
Peixe, LV
MICROBIAL DRUG RESISTANCE, 2002, 8 (02) : 93 - 97
[22] A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate
Yum, JH
Yong, DG
Lee, K
Kim, HS
Chong, YS
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 42 (03) : 217 - 219
[23] Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae
Jeong, SH
Lee, K
Chong, YS
Yum, JH
Lee, SH
Choi, HJ
Kim, JM
Park, KH
Han, BH
Lee, SW
Jeong, TS
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 397 - 400
[24] The first identification of an extended-spectrum β-lactamase-producing Escherichia coli from Norwegian livestock
Sunde, M.
Tharaldsen, H.
Solheim, H.
Norstroem, M.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S272 - S272
[25] The first metallo-β-lactamase producing clinical isolate of Pseudomonas aeruginosa in Norway
Samuelsen, O.
Toleman, M. A.
Hermansen, N. O.
Aasnaes, B.
Haldorsen, B.
Sundsfjord, A.
Walsh, T. R.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S378 - S378
[26] First detection of metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia
Villegas, MV
Lolans, K
Olivera, MD
Suarez, CJ
Correa, A
Queenan, AM
Quinn, JP
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 226 - 229
[27] Detection of Pseudomonas aeruginosa producing metallo-β-lactamase VIM-2 in a central hospital from Portugal
A. Pena
A. M. Donato
A. F. Alves
R. Leitão
O. M. Cardoso
European Journal of Clinical Microbiology & Infectious Diseases, 2008, 27 : 1269 - 1271
[28] Detection of Pseudomonas aeruginosa producing metallo-β-lactamase VIM-2 in a central hospital from Portugal
Pena, A.
Donato, A. M.
Alves, A. F.
Leitao, R.
Cardoso, O. M.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2008, 27 (12) : 1269 - 1271
[29] Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital:: clinical and epidemiological implications
Pena, C.
Suarez, C.
Tubau, F.
Gutierrez, O.
Dominguez, A.
Oliver, A.
Pujol, M.
Gudiol, F.
Ariza, J.
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (10) : 1026 - 1029
[30] Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact
Oteo, Jesus
Perez-Vazquez, Maria
Campos, Jose
CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (04) : 320 - 326

← 1 2 3 4 5 →